These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


255 related items for PubMed ID: 8371586

  • 1. Immunophenotypic characteristics of blast crisis of chronic myeloid leukaemia: correlations with clinico-biological features and survival.
    Urbano-Ispizua A, Cervantes F, Matutes E, Villamor N, Pujades A, Sierra J, Feliu E, Vives-Corrons JL, Montserrat E, Rozman C.
    Leukemia; 1993 Sep; 7(9):1349-54. PubMed ID: 8371586
    [Abstract] [Full Text] [Related]

  • 2. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.
    Khalidi HS, Brynes RK, Medeiros LJ, Chang KL, Slovak ML, Snyder DS, Arber DA.
    Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [The morphological, immunophenotypical and cytogenetic characteristics study of blast crisis in chronic myeloid leukemia].
    Tang X, Wu D, Xue Y, Zhu M, Lu D, Ruan C.
    Zhonghua Nei Ke Za Zhi; 2002 Oct; 41(10):685-7. PubMed ID: 12485536
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immunophenotype and ultrastructural studies in blast crisis of chronic myeloid leukemia.
    Nair C, Chopra H, Shinde S, Barbhaya S, Kumar A, Dhond S, Yejamanam B, Sapre R, Chougule A, Advani S.
    Leuk Lymphoma; 1995 Oct; 19(3-4):309-13. PubMed ID: 8535224
    [Abstract] [Full Text] [Related]

  • 10. [Immunophenotype of blast crisis in chronic myeloid leukemia].
    Favre G, Passweg J, Hoffmann T, Speck B, Gratwohl A, Tichelli A.
    Schweiz Med Wochenschr; 1998 Oct 17; 128(42):1624-6. PubMed ID: 9824896
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Immunogenotypes and surface marker analysis in Ph1 positive chronic myelogenous leukemia in the blastic crisis].
    Ohyashiki JH, Kawakubo K, Murakami T, Toyama K.
    Nihon Rinsho; 1992 Jun 17; 50(6):1262-6. PubMed ID: 1518143
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Immunophenotypic, genomic and clinical characteristics of blast crisis of chronic myelogenous leukaemia.
    Hernández JM, González-Sarmiento R, Martin C, González M, Sánchez I, Corral J, Orfao A, Cañizo MC, San Miguel JF, López-Borrasca A.
    Br J Haematol; 1991 Nov 17; 79(3):408-14. PubMed ID: 1751368
    [Abstract] [Full Text] [Related]

  • 19. Immunological classification of chronic myeloid leukemia distinguishes chronic phase, imminent blastic transformation, and acute lymphoblastic leukemia.
    Schmetzer HM, Gerhartz HH.
    Exp Hematol; 1997 Jun 17; 25(6):502-8. PubMed ID: 9197328
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.